65.48
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
Is Cidara Therapeutics Inc. a good long term investmentMarket-beating returns - Autocar Professional
Cidara more than doubles on phase 2 flu preventative data - MSN
What analysts say about Cidara Therapeutics Inc. stockHigh-yield portfolio picks - jammulinksnews.com
(CDTX) On The My Stocks Page - news.stocktradersdaily.com
What drives Cidara Therapeutics Inc. stock priceBreakthrough profit margins - jammulinksnews.com
ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews
Cidara Therapeutics Inc. Stock Analysis and ForecastFree Predictions - jammulinksnews.com
Growth or Bubble? Unpacking CDTX Stock Surge - timothysykes.com
Cidara Therapeutics stock hits 52-week high at 56.85 USD - Investing.com India
Cidara Therapeutics stock hits 52-week high at 56.85 USD By Investing.com - Investing.com Nigeria
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Brokerages - Defense World
What makes Cidara Therapeutics Inc. stock price move sharplyWatchlist Winner Update - Newser
Why Cidara Therapeutics Inc. stock attracts strong analyst attentionConsistent Growth Alert - newser.com
Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates - insights.citeline.com
Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics - Business Wire
Cidara Therapeutics announces inclusion in the Russell 2000 and 3000 indexes - MSN
Cidara Therapeutics shares rise 1.47% premarket after granting inducement awards to new employees. - AInvest
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Cidara Therapeutics shares fall 5.99% after-hours following inducement grants announcement. - AInvest
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains - TradingView
hVIVO reports positive results from Cidara’s Phase 2b influenza study By Investing.com - Investing.com Canada
(CDTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Phathom Pharmaceuticals shares rise 1.47% premarket after Cidara Therapeutics closes $402.5 million stock offering. - AInvest
Cidara Therapeutics prices upsized $350 milion stock offering at $44 - MSN
Cidara Therapeutics Prices $350 Million Public Offering - MarketScreener
Cidara Therapeutics (CDTX) Price Target Raised by RBC Capital | CDTX Stock News - GuruFocus
Cidara Therapeutics announces $250M public stock offering - MSN
Cidara stock surges as H.C. Wainwright raises price target on trial data By Investing.com - Investing.com South Africa
Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offering - MSN
Form 424B5 Cidara Therapeutics, - StreetInsider
Cidara Therapeutics (CDTX) to Launch $250M Public Offering | CDT - GuruFocus
Cidara Therapeutics plans $250 million common stock offering By Investing.com - Investing.com Canada
Cidara Therapeutics (CDTX) Price Target Boosted Following Positi - GuruFocus
Cidara Therapeutics (CDTX) Receives Strong Buy Rating from WBB Securities | CDTX Stock News - GuruFocus
Cidara Therapeutics Stock Rises as Strategic Partnerships Strengthen Position - timothysykes.com
Cidara Therapeutics Announces Positive Topline Results From Its Phase 2B Navigate Trial - TradingView
Cidara Therapeutics stock rockets after positive flu prevention trial results By Investing.com - Investing.com UK
Cidara Therapeutics Approves Key Amendments at Annual Meeting - TipRanks
(CDTX) Proactive Strategies - news.stocktradersdaily.com
Cidara Therapeutics (CDTX) Receives Buy Rating from HC Wainwrigh - GuruFocus
H.C. Wainwright assumes coverage on Cidara stock with buy rating By Investing.com - Investing.com UK
H.C. Wainwright Initiates Coverage on Cidara Therapeutics (CDTX) with Strong Outlook | CDTX Stock News - GuruFocus
Cidara Therapeutics (NASDAQ:CDTX) Given Overweight Rating at Cantor Fitzgerald - Defense World
Cidara Therapeutics (CDTX) Reiterates Overweight Rating by Canto - GuruFocus
(CDTX) Investment Analysis - news.stocktradersdaily.com
Millennium Management LLC Raises Stock Holdings in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World
Citizens JMP Reaffirms Their Buy Rating on Cidara Therapeutics (CDTX) - The Globe and Mail
Cidara Therapeutics stock maintains strong rating at Citizens JMP By Investing.com - Investing.com Canada
Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $36.00 at Needham & Company LLC - Defense World
Insider Buying: Chrysa Mineo Acquires Shares of Cidara Therapeutics Inc (CDTX) - GuruFocus
Needham raises Cidara Therapeutics stock price target to $36 - Investing.com
Cidara Therapeutics (CDTX) Price Target Raised by Needham | CDTX Stock News - GuruFocus
Cidara Therapeutics (NASDAQ:CDTX) Given Market Outperform Rating at JMP Securities - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):